Li Zhongmin, Yang Lei, Du Changzheng, Fang Xuedong, Wang Ning, Gu Jin
Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute, Beijing, China.
Oncotarget. 2017 Apr 11;8(15):24593-24603. doi: 10.18632/oncotarget.15598.
Population-based epidemiologic studies about colorectal cancer are lacking in China. This study aims to provide a basis for colorectal cancer screening and prevention, through analysis and comparisons the characteristics of the trends in colorectal cancer incidence in Beijing and selected representative regions.
The annual incidence rate in Beijing region increased significantly, from 9.40/100,000 in 1998 to 18.61/100,000 in 2012. The stratified rate showed that the incidence of distal colon adenocarcinoma increased substantially in men, especially in those aged > 75 years and residing in urban areas. Although the incidence rate in Beijing is still lower than in Shanghai, Jiashan, and Hong Kong in China, it is increasing rapidly. Further, the incidence rate in Beijing is lower than in New York, Oxford and Osaka, but higher than in Mumbai and Kyadondo. The incidence trend in Beijing is increasing especially in older groups, while in other regions such as New York, it is decreasing in these age groups.
Colorectal cancer incidence data were obtained from Beijing Cancer Registry and Cancer Incidence in Five Continents Plus database. All incidence rates were age-standardized according to Segi's world population. Incidence trends were characterized by calculating the annual percent changes using the Joinpoint Regression Program.
Compared with other regions, Beijing has a medium level of colorectal cancer incidence, however, it is increasing significantly. There are obvious differences in the cancer subsite, sex and age distributions between Beijing and other regions. Prevention and screening of colorectal cancer in Beijing should be strengthened.
中国缺乏基于人群的结直肠癌流行病学研究。本研究旨在通过分析和比较北京及选定代表性地区结直肠癌发病率趋势的特征,为结直肠癌筛查和预防提供依据。
北京地区的年发病率显著上升,从1998年的9.40/10万增至2012年的18.61/10万。分层率显示,男性远端结肠腺癌发病率大幅上升,尤其是75岁以上且居住在城市地区的男性。尽管北京的发病率仍低于中国的上海、嘉善和香港,但上升迅速。此外,北京的发病率低于纽约、牛津和大阪,但高于孟买和卡延多。北京的发病率趋势在老年人群中尤其呈上升趋势,而在纽约等其他地区,这些年龄组的发病率则在下降。
结直肠癌发病率数据来自北京肿瘤登记处和《五大洲癌症发病率加》数据库。所有发病率均根据Segi世界人口进行年龄标准化。发病率趋势通过使用Joinpoint回归程序计算年度百分比变化来表征。
与其他地区相比,北京的结直肠癌发病率处于中等水平,然而,其发病率正在显著上升。北京与其他地区在癌症亚部位、性别和年龄分布方面存在明显差异。应加强北京结直肠癌的预防和筛查。